Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_provenance.
- befree-2016 importedOn "2016-02-19" NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_provenance.
- NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_assertion wasGeneratedBy ECO_0000203 NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_provenance.
- NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_assertion wasDerivedFrom befree-2016 NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_provenance.
- NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_assertion SIO_000772 10690891 NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_provenance.
- NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_assertion evidence source_evidence_literature NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_provenance.
- NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_assertion description "[Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable suppression of GH and PRL release from GH-secreting human adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_provenance.